BeOne Medicines
ONC
#720
Rank
NZ$58.82 B
Marketcap
NZ$531.59
Share price
-1.67%
Change (1 day)
21.36%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Sustainability Reports

Thumbnail BeOne Medicines Sustainability Report 2023

Sustainability Report 2023

Language: English

View Sustainability Report
Thumbnail BeOne Medicines Sustainability Report 2020

Sustainability Report 2020

Language: English

View Sustainability Report